Drug intelligence / Profile preview

acacia longifolia pollen

Development stage
Unknown
Lead developer
Jubilant HollisterStier
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal, Percutaneous
01

Overview

Acacia longifolia pollen is an allergenic extract derived from the pollen of the Sydney golden wattle (*Acacia longifolia*) tree. [1, 5] It is a biologic product used for both the diagnosis and immunotherapy of allergies caused by sensitization to this pollen. The mechanism of action involves modulating the immune system to induce tolerance in patients with IgE-mediated allergic responses, thereby reducing symptoms like hay fever (allergic rhinitis), allergic asthma, and allergic conjunctivitis. [7, 5] For diagnosis, it is administered via percutaneous skin prick testing. For immunotherapy, it is given through subcutaneous injections. [1] First approved in the United States in 1941, it is regulated as a non-standardized allergenic extract under a Biologic License Application (BLA). A number of companies manufacture this extract, including Jubilant HollisterStier, Antigen Laboratories, ALK-Abello, and Allergy Laboratories. [1] One specific formulation, CENTER-AL, is an alum-precipitated version of the extract designed for subcutaneous immunotherapy. [4]

Brand names
CENTER-AL
Other names
Sydney golden wattle pollen extractSydney golden wattle pollenwestern yarrow pollen

Beyond the preview

Go deeper on acacia longifolia pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acacia longifolia pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call